153
Views
4
CrossRef citations to date
0
Altmetric
Articles

A Comparison of Attitudes Toward Pharmacological Treatment Versus Enhancement Under Competitive and Noncompetitive Conditions

Pages 80-90 | Published online: 14 Apr 2014
 

Abstract

Background: The goal of this study was to examine how the variables of treatment versus enhancement, competition, type of behavioral characteristic, and a person's history of enhancer or psychotropic medication use are related to acceptability and ethical concerns raised by psychotropic drug use. Methods: Participants completed online surveys probing acceptability (e.g., a person has the right to use a drug) and ethical concerns (e.g., fairness, authenticity) of a hypothetical drug described as effective in altering different behavioral characteristics under either competitive or noncompetitive situations. Past use of enhancing agents or psychotropic medication on attitudes toward enhancement was also examined. Results: Ethical concerns were greater for enhancement than for prescribed usage. Competitive framing affected attitudes under the enhancement but not the treatment conditions. Participants who have used prescribed medications for either enhancement or therapeutic reasons often had more generally positive attitudes toward enhancer use.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 137.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.